Research HighlightsResearch

Neurology Update: Neuropathies

September 30, 2019

Second dose of intravenous immunoglobulin for Guillain-Barre syndrome

The preliminary results of the Dutch SIDGBS (second dose of intravenous immunoglobulin for severe Guillain-Barre syndrome) were presented at the Peripheral Nerve Society meeting in Genoa, June 2019.

Please continue here.

 

 

You may also like

Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity

January 5, 2021

EAN Coordinating Panel on Rare Neurological Diseases

November 6, 2019

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study

February 25, 2021

Dystonia Europe 25th Anniversary Lunch in EU Parliament in Brussels

May 8, 2018

CSF biomarkers in patients with COVID-19 and neurological symptoms A case series

November 4, 2020

The relationship between COVID-19’s severity and ischemic stroke: a systematic review and meta-analysis

June 2, 2021

Characteristics and Outcomes Among US Patients Hospitalized for Ischemic Stroke Before vs During the COVID-19 Pandemic

June 2, 2021

Remdesivir for the treatment of Covid-19 — preliminary report

June 3, 2020

Scientific Committee Snapshot: Eavan McGovern

January 1, 2020

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

March 3, 2021

Leave a Comment